Logo
RUTGERS CANCER INSTITUTE OF NEW JERSEY IN THE NEWS SEPTEMBER 2021
Delivered by Corporate Media Relations
Fullintel Daily Digest
Service Lines
Fullintel Daily Digest
Aiming to Be America’s Leading Intersection for Economic Growth and Opportunities
Sep 01 | Online Publication  |  Reach: 261,725 | Sentiment : Positive
Share article :  |  |  | 
Pittsburgh Business Times (Pittsburgh, PA) - The Hub will provide studios and work spaces; wet and dry laboratories; conference areas; makers spaces; and a market hall, making the county the heart of invention and innovation. And only blocks away, the Jack and Sheryl Morris Cancer Center, which will become the state’s first free-standing cancer center, has received a $25 million commitment from the county. Lead partners RWJBarnabas Health and Rutgers Cancer Institute of New Jersey will collaborate with Middlesex County to establish training initiatives for residents to gain employment at the center, particularly an innovative internship program and specialized curricula for Middlesex College students. Read More
New Chief of Thoracic & Head & Neck Medical Oncology Named
Article image
Sep 01 | Online Publication  |  Reach: 1,063,769 | Sentiment : Positive
Share article :  |  |  | 
New Jersey Patch - Expanding its multidisciplinary teams of highly specialized experts uniquely focused on the management of head and neck cancers and cancer of the lung, pleura and mediastinum, Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have welcomed Missak Haigentz, Jr., MD, as chief of Thoracic and Head and Neck Medical Oncology and clinical director for Oncology Integration. Read More
Haigentz Named New Chief of Thoracic and Head and Neck Medical Oncology at Rutgers Cancer Institute
Article image
Sep 01 | Online Publication  |  Reach: 2,093 | Sentiment : Positive
Share article :  |  |  | 
ROI-NJ - Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have named Dr. Missak Haigentz as chief of thoracic and head and neck medical oncology and clinical director for oncology integration. Read More
Banking on Life Sciences: How One NJ County Is Investing in Its Future
Sep 01 | Online Publication  |  Reach: N/A | Sentiment : Positive
Share article :  |  |  | 
The News Yard - Castor points to two major projects the county helped facilitate as examples of its future regional advantage. The $750 million Rutgers Cancer Institute of New Jersey, Jack & Sheryl Morris Cancer Center will open in 2024 as the state’s first freestanding cancer center. That same year Hub New Brunswick will open in downtown New Brunswick. It’s designed to foster research, entrepreneurship, innovation and startup incubation. It will bring together under one roof Princeton University, Rutgers University, Hackensack Meridian Health and RWJBarnabas Health as core partners and initial tenants. Read More
Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination With Atezolizumab for Advanced Solid Tumors
Sep 08 | Online Publication  |  Reach: 2,183,342 | Sentiment : Positive
Share article :  |  |  | 
Yahoo! Finance - Observations I and II are double combination treatments, which will be conducted in parallel, whereas Observation III (the triple combination treatment) will be initiated only after a thorough review of the safety data from Observations I and II. Each Observation period will last 3 weeks. This study plans to recruit approximately 63 patients. The first patient was dosed at Florida Cancer Specialists - Lake Mary Cancer Center, while the study is also going to recruit patients from the University of Colorado Cancer Center, Rutgers Cancer Institute of New Jersey and Stephenson Cancer Center in Oklahoma. Read More
Also syndicated in:
The Associated Press, Yahoo Lifestyle, BioSpace, StreetInsider.com, Benzinga.com, News Nation USA, KPVI, Le Lezard.com, TickerTech.com and WFMZ-TV Online
Syndicated Reach: TM - 37,206,309
Understanding Emotional Health and Childhood Cancer
Article image
Sep 07 | Online Publication  |  Reach: 1,063,769 | Sentiment : Neutral
Share article :  |  |  | 
New Jersey Patch - Some childhood cancer survivors will experience medical problems related to cancer therapy later in life known as "late effects," however, impairment from cancer treatment may not be the only factor to consider. Karen Long-Traynor, PhD, clinical psychologist in the Pediatric Hematology/Oncology Program at Rutgers Cancer Institute of New Jersey, addresses the psychological effects of childhood cancer on children and their families. Read More
Negative Trials Close the Book on Once-Promising SCLC Drug
Sep 07 | Online Publication| Pam Harrison  |  Reach: 82,201 | Sentiment : Neutral
Share article :  |  |  | 
MedPage Today - In a phase I/II study reported by Jyoti Malhotra, MD, MPH, of Rutgers Cancer Institute of New Jersey, and colleagues, 42 previously treated patients with extensive-stage SCLC received Rova-T in combination with nivolumab (Opdivo) plus or minus ipilimumab (Yervoy). Read More
Four Independent Studies Show Rovalpituzumab Tesirine Ineffective Against Small Cell Lung Cancer
Sep 07 | Online Publication  |  Reach: 872,418 | Sentiment : Neutral
Share article :  |  |  | 
Science Daily - A second study published in JTO, "A Phase 1-2 Study of Rovalpituzumab Tesirine in Combination With Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Extensive-Stage SCLC," the researchers, led by Dr. Jyoti Malhotra, Rutgers Cancer Institute of New Jersey, New Brunswick, N.J., found that "Despite encouraging antitumor activity in previously treated ES SCLC, combination therapy with Rova-T and nivolumab plus or minus ipilimumab was not well tolerated at the dose levels and administration schedules evaluated." Read More
Also syndicated in:
News Concerns
Syndicated Reach: TM - N/A
Advancements in Prostate Cancer Treatments
Article image
Sep 08 | Online Publication  |  Reach: 1,063,769 | Sentiment : Neutral
Share article :  |  |  | 
New Jersey Patch - Prostate cancer is the most common type of cancer among men in the United States aside from skin cancer, according to the Centers for Disease Control and Prevention (CDC). Because prostate cancer is so common, the potential impact of each innovation by physicians and researchers has the power to benefit many men and their families. Over the last decade, advancements have been made in the diagnosis and treatment of prostate cancer that are saving more lives. Read More
Understanding Good Prostate Health for Cancer Prevention
Sep 08 | Online Publication  |  Reach: 1,063,769 | Sentiment : Neutral
Share article :  |  |  | 
New Jersey Patch - The American Cancer Society estimates about one in eight men will be diagnosed with prostate cancer during his lifetime. Men and their loved ones should be proactive about prostate health all year long by being aware of prostate cancer symptoms and learning how to maintain good prostate health. Tina Mayer, MD, medical oncologist in the Prostate Cancer Program at Rutgers Cancer Institute of New Jersey and an associate professor of medicine at Rutgers Robert Wood Johnson Medical School, shares more about prostate health. Read More
Women's Wellness: Gynecologic Cancers
Article image
Sep 08 | Online Publication  |  Reach: 1,063,769 | Sentiment : Neutral
Share article :  |  |  | 
New Jersey Patch - Gynecologic cancer is the growth and spread of cancer cells in the cervix, ovaries, uterus, fallopian tubes, vagina, and vulva as well as in peritoneum—also known as the reproductive organs, which make any woman at risk for developing one of these cancers. The first step to managing these diseases is to increase your own knowledge of gynecologic cancers. James K. Aikins, Jr., MD, FACOG, FACS, is chief of Gynecologic Oncology at Rutgers Cancer Institute of New Jersey and manages the care of patients at this location and at Robert Wood Johnson University Hospital Hamilton, an RWJBarnabas Health facility. He is also an associate professor of Obstetrics, Gynecology and Reproductive Sciences at Rutgers Robert Wood Johnson Medical School and shares more about these cancers. Read More
Also syndicated in:
Medical Xpress
Syndicated Reach: TM - 59,179
Blood Cancer Cures and Care: Addressing Leukemia and Lymphoma
Article image
Sep 09 | Online Publication  |  Reach: 1,063,769 | Sentiment : Positive
Share article :  |  |  | 
New Jersey Patch - Rutgers Cancer Institute of New Jersey in collaboration with RWJBarnabas Health offers this novel therapy and hosts a number of clinical trials for these types of cancers. These discoveries have helped improve the rate at which blood cancers can be managed and cured. Read More
Also syndicated in:
Medical Xpress and HealthNewsDigest.com
Syndicated Reach: TM - 59,450
Cancer Prevention – Understanding Good Prostate Health
Sep 09 | Online Publication  |  Reach: 271 | Sentiment : Positive
Share article :  |  |  | 
HealthNewsDigest.com - Tina Mayer, MD, medical oncologist in the Prostate Cancer Program at Rutgers Cancer Institute of New Jersey and an associate professor of medicine at Rutgers Robert Wood Johnson Medical School, shares more about prostate health. Read More
Five Facts About Thyroid Cancer
Article image
Sep 09 | Online Publication  |  Reach: 1,063,769 | Sentiment : Neutral
Share article :  |  |  | 
New Jersey Patch - Thyroid cancer occurs when a cell in your thyroid undergoes mutation which cause the cells to grow and multiply rapidly. Amanda M. Laird, MD, FACS, chief of endocrine surgery at Rutgers Cancer Institute of New Jersey and associate professor of surgery at Rutgers Robert Wood Johnson Medical School, shares five facts about thyroid cancer everyone should know. Read More
Women’s Wellness: Types of Gynecologic Cancers and Their Warning Signs
Article image
Sep 09 | Online Publication  |  Reach: N/A | Sentiment : Neutral
Share article :  |  |  | 
Mega Doctor News - James K. Aikins, Jr., MD, FACOG, FACS, is chief of Gynecologic Oncology at Rutgers Cancer Institute of New Jersey and manages the care of patients at this location and at Robert Wood Johnson University Hospital Hamilton, an RWJBarnabas Health facility. Read More
5 Facts About Thyroid Cancer
Sep 10 | Online Publication  |  Reach: 271 | Sentiment : Neutral
Share article :  |  |  | 
HealthNewsDigest.com - The thyroid, a key part of the endocrine system, is a small gland at the base of your neck that produces a hormone that helps control your body's metabolism. Thyroid cancer occurs when a cell in your thyroid undergoes mutation which cause the cells to grow and multiply rapidly. Amanda M. Laird, MD, FACS, chief of endocrine surgery at Rutgers Cancer Institute of New Jersey and associate professor of surgery at Rutgers Robert Wood Johnson Medical School, shares five facts about thyroid cancer everyone should know. Read More
Rova-T Ineffective Against Small Cell Lung Cancer
Sep 11 | Online Publication  |  Reach: N/A | Sentiment : Neutral
Share article :  |  |  | 
Sciencebeta - In the second study published in JTO, the researchers, led by Dr. Jyoti Malhotra, Rutgers Cancer Institute of New Jersey, found that, despite encouraging antitumor activity in previously treated ES SCLC, combination therapy with Rova-T and nivolumab plus or minus ipilimumab was not well tolerated at the dose levels and administration schedules evaluated. Read More
Exploring the Impact of Blood Clots in the Veins During Renal Cell Carcinoma Surgery
Sep 13 | Online Publication  |  Reach: 59,179 | Sentiment : Neutral
Share article :  |  |  | 
Medical Xpress - Venous thromboembolism refers to blood clots in the veins, which is a serious yet preventable medical condition and is often seen with advanced cancers. Researchers at Rutgers Cancer Institute of New Jersey explored the impact of VTE during surgery for renal cell carcinoma, also known as kidney cancer, in a cohort study of patients undergoing elective surgical resection for a cancerous kidney mass. The results of the work were presented as posters by authors Hiren V. Patel, MD, Ph.D., and Rutgers Robert Wood Johnson Medical School urologists at the American Urological Association 2021 Annual Meeting in Las Vegas, Nevada. It has been announced. Senior Author Eric A. Singer, MD, MA, MS, FACS, FASCO, Deputy Chief of Urology and Director of the Kidney Cancer Program at the Rutgers Cancer Institute, and Surgery Department of Radiology at Rutgers Robert Wood Johnson Medical College. Read More
Also syndicated in:
Florida News Times and News-Medical.Net
Syndicated Reach: TM - 171,284
Rutgers Gets NIH Grant to Further Single-Cell RNA Sequencing
Article image
Sep 13 | Online Publication| Michelle Edelstein  |  Reach: 1,063,769 | Sentiment : Neutral
Share article :  |  |  | 
New Jersey Patch - "This grant will help us develop novel statistical models for jointly analyzing and comparing scRNA-seq data from heterogeneous biological samples, such as multiple patients, developmental stages, or related species," says Li, who is also an associate research member in the Cancer Prevention and Control Program at Rutgers Cancer Institute. "Ultimately, we hope this work will yield efficient and broadly applicable statistical and bioinformatics tools for generating substantial insights into identifying key cells, pathways, gene interactions, and RNA transcripts associated with various biological contexts, including human disease." Read More
Addition of New Hematologist/Oncologist in the RWJBarnabas Health Southern Region Will Elevate the Level of Specialty Care in Benign and Malignant Blood Disorder
Article image
Sep 15 | Online Publication  |  Reach: N/A | Sentiment : Positive
Share article :  |  |  | 
Atlantic Highlands Herald - Hussam Eltoukhy, MD, a blood cancer specialist with expertise in benign and malignant blood disorders including leukemia, lymphoma, multiple myeloma and anemia, has joined the medical staffs at Community Medical Center, Monmouth Medical Center, Monmouth Medical Center Southern Campus and Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center. Read More
Harnessing Immunogenic Cell Death for Cancer
Sep 18 | Online Publication  |  Reach: 1,953,249 | Sentiment : Neutral
Share article :  |  |  | 
Nature Reviews Rheumatology - Backed by a strong intellectual property position that includes an exclusive global license to the family of compounds, Phosplatin is advancing its R&D portfolio through collaborations with leading research institutions and biopharma companies. These include Weill Cornell Medicine, the Fred Hutchinson Cancer Research Center, the Rutgers Cancer Institute of New Jersey, the Institute for the Research of Cancer, Montpellier, France, the University of Lausanne, Switzerland and the University of Zaragoza in Spain. Read More
CAR T-Cell Therapy Emerges as Option in Follicular Lymphoma
Sep 20 | Online Publication| Mary Ellen  |  Reach: 234,366 | Sentiment : Neutral
Share article :  |  |  | 
Clinical Orthopaedics and Related Research - “It's a big deal,” stated Dennis Cooper, MD, Chief of Blood and Marrow Transplantation at Rutgers Cancer Institute of New Jersey, with regards to the axi-cel approval. Follicular lymphoma patients who have relapsed after two lines of therapy don't have many good options, he said. “The length of response gets less and less with each line of therapy.” Read More
Addressing the COVID Impact: Mammograms and Moving Forward
Article image
Sep 21 | Online Publication  |  Reach: 1,063,769 | Sentiment : Positive
Share article :  |  |  | 
New Jersey Patch - Federal guidelines along with state and local regulations led to a disruption in routine preventative cancer screenings, such as mammograms, in an effort to reduce the risk of the spread of COVID-19 in healthcare settings. According to the Centers for Disease Control and Prevention, new cancer diagnoses have declined significantly during the pandemic, which correlates to delays and cancellations in routine screenings. This may lead to cancers being diagnosed at a more advanced stage of the disease, which can present treatment challenges as well as adversely impact survival. It is more important now than ever to schedule your annual mammogram. Read More
Also syndicated in:
HealthNewsDigest.com
Syndicated Reach: TM - 271
Proton Therapy for Breast Cancer
Sep 22 | Online Publication  |  Reach: 271 | Sentiment : Positive
Share article :  |  |  | 
HealthNewsDigest.com - Bruce Haffty, MD, MS, president of Radiation Oncology and associate vice chancellor for cancer programs at the Rutgers Cancer Institute of New Jersey and director of the Radiation Oncology system at RWJ Barnabas Health, treated a breast cancer patient with proton therapy which is a unique type of radiation treatment that can precisely target and deliver high doses of radiation to a tumor to kill cancerous cells. The patient, who was in her early 30s and in the early months of her first pregnancy while facing a second breast cancer diagnosis, received radiation therapy in her previous diagnosis. Therefore, proton therapy was the best option to treat the affected area while the previously irradiated surrounding tissue was spared the additional radiation. Read More
Also syndicated in:
Remo News, Newsfounded and Medical Xpress
Syndicated Reach: TM - 59,179
Softball Tournament Proceeds Benefit Pancreatic Cancer Search at Rutgers Cancer Institute
Sep 22 | Online Publication  |  Reach: 3,465 | Sentiment : Positive
Share article :  |  |  | 
Centraljersey.com - All proceeds collected during registration will directly enable Rutgers Cancer Institute of New Jersey physician-scientists to expand pancreatic cancer research and clinical trials, according to the statement. The annual event is meant to increase awareness and raise funds to aid research and support the work being done by the RCINJ. Read More
Three Advances in Breast Cancer Treatment Are Saving More Lives
Article image
Sep 22 | Online Publication  |  Reach: 1,063,769 | Sentiment : Positive
Share article :  |  |  | 
New Jersey Patch - There are more options for breast cancer patients now than ever before. Lindsay Potdevin, MD, surgical oncologist at Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital Somerset, an RWJBarnabas Health facility, shares more about these advances that have made a notable impact on the lives of breast cancer patients. Read More
3 Advances in Breast Cancer Treatment Are Saving More Lives
Sep 23 | Online Publication  |  Reach: 271 | Sentiment : Positive
Share article :  |  |  | 
HealthNewsDigest.com - Lindsay Potdevin, MD, surgical oncologist at Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital Somerset, an RWJBarnabas Health facility, shares more about these advances that have made a notable impact on the lives of breast cancer patients. Read More
Abdominal Fat & Worse Outcomes for Black Breast Cancer Survivors
Article image
Sep 23 | Online Publication  |  Reach: 1,063,769 | Sentiment : Positive
Share article :  |  |  | 
New Jersey Patch - Elisa V. Bandera, MD, PhD, chief of Cancer Epidemiology and Health Outcomes and co-leader of the Cancer Prevention and Control Program at Rutgers Cancer Institute of New Jersey, professor of medicine at Rutgers Robert Wood Johnson Medical School, and professor of epidemiology at Rutgers School of Public Health, is lead author of the study and shares more about the findings published online in JAMA Oncology. Read More
Also syndicated in:
News-Medical.Net and Hands Better
Syndicated Reach: TM - 171,284
Middlesex County Raises Funds for Pancreatic Cancer Research
Sep 24 | Online Publication| Sarah Salvadore  |  Reach: 1,063,769 | Sentiment : Positive
Share article :  |  |  | 
New Jersey Patch - The event was held at the Thomas Edison Park and was hosted by the Middlesex County Office of Parks and Recreation, along with the Board of County Commissioners. The aim was to increase community awareness about the disease and raise funds to aid cancer research at the Rutgers Cancer Institute of New Jersey. Read More
New Chief of Thoracic and Head and Neck Medical Oncology Named to New Jersey Cancer Center
Sep 25 | Online Publication  |  Reach: N/A | Sentiment : Positive
Share article :  |  |  | 
The ASCO Post - Dr. Haigentz will co-lead the Head and Neck Oncology Program and the Thoracic Oncology Program at Rutgers Cancer Institute and collaborate with colleagues across RWJBarnabas Health in the management of patient care in these areas. In his role as Clinical Director for Oncology Integration for RWJBarnabas Health, he will promote clinical integration and facilitate the coordination of patient care across the oncology service line to improve patient safety and efficiency. Read More
Addressing COVID's Impact: Mammograms and Moving Forward, Page No: 41
Sep 29 | Newspaper  |  Reach: 4,291,816 | Sentiment : Positive
Share article :  |  |  | 
Hamilton Post - If you’ve scheduled a mammogram soon after receiving the COVID-19 vaccine, its important to tell your doctor when and in which arm you received the injection. Based on your situation, they can discuss with you if you should change your mammogram appointment. Read More
A Nearly Decade-Long Research Project Yields a Breakthrough in Understanding Cancer and How to Attack It
Sep 30 | Newspaper| Mark Johnson  |  Reach: 40,761 | Sentiment : Neutral
Share article :  |  |  | 
Milwaukee Journal Sentinel - One hallmark of the studies by Krogan and his colleagues is collaboration between multiple labs. The cancer papers included contributions from Rutgers Cancer Institute, Oregon Health and Science University, the J. David Gladstone Institutes in San Francisco and the University of California, San Diego. Read More
Also syndicated in:
Wisconsin Rapids Tribune
Syndicated Reach: TM - N/A
Recommended by Fullintel Analysts

You are currently subscribed as info@fullintel.com. For further assistance, please contact Customer Service at support@fullintel.com

Unsubscribe   |   Privacy Policy

Copyright 2022 Fullintel, LLC. All Rights Reserved.

Powered by
Fluid structures